Scotland’s TC BioPharm joins bluebird to develop next-gen CAR-TUS cancer biotech bluebird bio has joined with TC BioPharm in a collaboration focused on gamma delta CAR-T Share XScotland’s TC BioPharm joins bluebird to develop next-gen CAR-Thttps://pharmaphorum.com/news/scotlands-tc-biopharma-joins-bluebird-develop-next-gen-car-t/
Scottish firm gets EU funding for ‘off the shelf’ cancer cell therapyFirst patients could be treated in 2019. Share XScottish firm gets EU funding for ‘off the shelf’ cancer cell therapyhttps://pharmaphorum.com/news/tcb-funding-off-shelf-cancer-therapy/